The current valuation score of Prothena Corporation PLC is 7.12, ranking 214 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -2.89, which is -62.73% below the recent high of -1.08 and -1254.48% above the recent low of -39.18.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.